EP300 and cancer: In this study, we show that simultaneous inhibition of a paralog pair (CBP and p300) causes synthetic lethality in SMARCA4/SMARCA2-deficient cancer cells and SS18–SSX fusion cancer cells; these results are similar to those obtained for SMARCB1-deficient cancer cells (19).